Yemi Adesokan

Company: Gnubiotics Sciences

Job title: Chief Executive & Scientific Officer

Seminars:

Uncovering a Glycopeptide-mediated T-cell Immunotherapy to Modulate Anti-tumour Immunity 2:30 pm

Showing the effect of delivery of glycopeptide conjugates to steer a multi-targeted, yet tumour-specific, T-cell response in epithelial cancer Revealing novel mechanism of action to uncover efficacy data Reviewing new abstract and data presented at the recent American Society of Clinical Oncology Conferences (ASCO)Read more

day: Focus Day